Free Newsletter
Ireland welcomes Takeda, Pfizer
Takeda's first manufacturing facility outside of Japan, an API plant, has opened in Dublin, thanks in part to the efforts of investment promotion agency IDA Ireland and the South Dublin County Council.
The multi-product plant joins the company's finished product operations on the Emerald Isle, located 15 miles south in Bray. Takeda cites expanding sales in the Europe and the U.S. as driving the decision to open the Dublin plant, which is used in the making of active ingredients for diabetes and sleep disorder drugs.
The Takeda announcement follows by less than two weeks a Pfizer announcement that it will invest $16 million in an R&D plant in Cork. IDA Ireland was also behind that deal. The new lab will be used to develop manufacturing technology to improve production process efficiency. It is currently under construction.
- here's the Takeda release
- see the Pfizer announcement
Related Articles:
Pfizer funds Irish R&D facility
Pfizer cuts 180 jobs in Ireland
Pfizer builds plant, creates jobs in Ireland
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: